Clinical trial · Interventional
Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
Prehabilitation for Advanced Ovarian Cancer Patients
NCT05047926CI-TRIAL-00093304completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical trial evaluates whether a prehabilitation program started at the time of neoadjuvant chemotherapy will affect surgical recovery in patients with stage IIIC-IV ovarian, fallopian tube, or primary peritoneal cancer. A prehabilitation program may improve the quality of life after surgery for patients with ovarian, fallopian tube, or primary peritoneal cancer.
Conditions
Conditions (7)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Ovarian Carcinoma | Ovarian Carcinoma | CURATED_BROADER | 0.78 |
| Stage IIIC Fallopian Tube Cancer AJCC v8 | Malignant Fallopian Tube Neoplasm | CURATED_BROADER | 0.78 |
| Stage IIIC Ovarian Cancer AJCC v8 | Malignant Ovarian Neoplasm | CURATED_BROADER | 0.78 |
| Stage IIIC Primary Peritoneal Cancer AJCC v8 | — | UNRESOLVED | — |
| Stage IV Fallopian Tube Cancer AJCC v8 | Malignant Fallopian Tube Neoplasm | CURATED_BROADER | 0.78 |
| Stage IV Ovarian Cancer AJCC v8 | Malignant Ovarian Neoplasm | CURATED_BROADER | 0.78 |
| Stage IV Primary Peritoneal Cancer AJCC v8 | — | UNRESOLVED | — |
Interventions
Interventions (8)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Behavioral Counseling | Behavioral | — | UNRESOLVED |
| Biospecimen Collection | Procedure | — | UNRESOLVED |
| Computed Tomography | Procedure | — | UNRESOLVED |
| Health Education | Behavioral | — | UNRESOLVED |
| Medical Device Usage and Evaluation | Other | — | UNRESOLVED |
| Nutritional Supplement Drink | Dietary Supplement | — | UNRESOLVED |
| Physical Activity | Other | — | UNRESOLVED |
| Survey Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Cohort 1 (surveys, CT, blood samples)
- description
- Patients undergoing primary surgical intervention complete surveys, undergo CT, and undergo collection of blood samples at baseline.
- interventionNames
- Other: Survey Administration
- Procedure: Computed Tomography
- Procedure: Biospecimen Collection
- type
- EXPERIMENTAL
- label
- Cohort 2 (exercise, supplement, Resilient Living)
- description
- Patients undergoing neoadjuvant chemotherapy complete physical activity for 30 minutes per day 3 times a week. Patients receive nutritional supplement drink up to 4.5 times daily, and complete Resilient Living program in-person or remotely over 60 minutes. Patients also undergo CT scans throughout the trial.
- interventionNames
- Dietary Supplement: Nutritional Supplement Drink
- Other: Physical Activity
- Other: Survey Administration
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age \>= 18 years old * Diagnosed with epithelial ovarian, fallopian tube, or primary peritoneal cancer based on imaging and physician diagnosis * Suspected Stage IIIC or IV disease based on clinician staging and imaging * Curative intent treatment with platinum-based chemotherapy * Planned surgical intervention at some point during treatment course * Ability to read English * No diagnosed severe cognitive impairment * Ability to provide consent * Ability to utilize technology to watch online modules for the Resilient Living Program Exclusion Criteria: * Hemiplegia or paraplegia * Current pregnancy
References
Publications (0)
Data not yet available
No reference posted for this study.